GLP-1 Drug Cost by State

Medicaid coverage for anti-obesity GLP-1 medications varies dramatically by state. Find your state to see what Medicaid covers, average costs, and your best options.

12 States

Cover GLP-1s for Obesity Under Medicaid

California Colorado Illinois Maryland Massachusetts Minnesota New York North Carolina Oregon Vermont Washington District of Columbia

39 States

Do NOT Cover Weight-Loss GLP-1s Under Medicaid

Most do cover GLP-1s for Type 2 diabetes (Ozempic, Mounjaro). Commercial insurance and compounded telehealth options available.

All 50 States + D.C.

✅ Medicaid covers weight-loss GLP-1s

→

Colorado

✅ Medicaid covers weight-loss GLP-1s

✅ Medicaid covers weight-loss GLP-1s

✅ Medicaid covers weight-loss GLP-1s

→

Massachusetts

✅ Medicaid covers weight-loss GLP-1s

✅ Medicaid covers weight-loss GLP-1s

✅ Medicaid covers weight-loss GLP-1s

→

North Carolina

✅ Medicaid covers weight-loss GLP-1s

✅ Medicaid covers weight-loss GLP-1s

✅ Medicaid covers weight-loss GLP-1s

✅ Medicaid covers weight-loss GLP-1s

✅ Medicaid covers weight-loss GLP-1s

→

What Determines GLP-1 Coverage in Your State?

State Medicaid programs set their own formularies within federal guidelines. Most states cover GLP-1 drugs prescribed for Type 2 diabetes (Ozempic, Mounjaro, Rybelsus) with prior authorization. Coverage for anti-obesity medications (Wegovy, Zepbound, Saxenda) is far less common because CMS historically classified obesity drugs as excluded from Medicaid.

That's changing. States like California, New York, Illinois, and North Carolina now cover GLP-1 AOMs for obesity, and more states are evaluating coverage. Federal legislative changes could mandate Medicaid AOM coverage nationally.